Cargando…
Past, Present and Future of Epigenetics in Adrenocortical Carcinoma
DNA methylation profiling has been suggested a reliable technique to distinguish between benign and malignant adrenocortical tumors, a process which with current diagnostic methods remains challenging and lacks diagnostic accuracy of borderline tumors. Accurate distinction between benign and maligna...
Autores principales: | Ettaieb, Madeleine, Kerkhofs, Thomas, van Engeland, Manon, Haak, Harm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281315/ https://www.ncbi.nlm.nih.gov/pubmed/32414074 http://dx.doi.org/10.3390/cancers12051218 |
Ejemplares similares
-
Health-Related Quality of Life in Adrenocortical Carcinoma
por: Steenaard, Rebecca V., et al.
Publicado: (2019) -
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing
por: Yin, Anyue, et al.
Publicado: (2020) -
Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality
por: Ettaieb, Madeleine H. T., et al.
Publicado: (2020) -
EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity
por: Steenaard, Rebecca V., et al.
Publicado: (2022) -
The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue
por: Steenaard, Rebecca V., et al.
Publicado: (2023)